Ardent Health, Inc. (NYSE:ARDT) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Ardent Health, Inc. (NYSE:ARDT) have been assigned an average rating of “Moderate Buy” from the eleven ratings firms that are covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating and nine have given a buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $19.3273.

A number of research analysts have recently commented on the stock. Wall Street Zen raised shares of Ardent Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 9th. Bank of America lowered shares of Ardent Health from a “neutral” rating to an “underperform” rating and dropped their price objective for the company from $15.50 to $14.60 in a report on Wednesday, July 16th. KeyCorp dropped their price objective on shares of Ardent Health from $24.00 to $20.00 and set an “overweight” rating for the company in a report on Thursday, August 7th. UBS Group started coverage on shares of Ardent Health in a report on Wednesday, September 10th. They issued a “buy” rating and a $17.00 price objective for the company. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Ardent Health from $18.00 to $15.00 and set a “neutral” rating for the company in a report on Monday, August 11th.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the company. Oliver Luxxe Assets LLC raised its holdings in Ardent Health by 1.5% during the 2nd quarter. Oliver Luxxe Assets LLC now owns 87,639 shares of the company’s stock worth $1,197,000 after purchasing an additional 1,319 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in Ardent Health during the 4th quarter worth approximately $27,000. Geode Capital Management LLC raised its holdings in Ardent Health by 0.6% during the 2nd quarter. Geode Capital Management LLC now owns 286,848 shares of the company’s stock worth $3,918,000 after purchasing an additional 1,769 shares during the last quarter. Squarepoint Ops LLC raised its holdings in Ardent Health by 1.8% during the 4th quarter. Squarepoint Ops LLC now owns 101,798 shares of the company’s stock worth $1,739,000 after purchasing an additional 1,798 shares during the last quarter. Finally, CWM LLC raised its holdings in Ardent Health by 990.6% during the 2nd quarter. CWM LLC now owns 2,203 shares of the company’s stock worth $30,000 after purchasing an additional 2,001 shares during the last quarter.

Ardent Health Stock Down 3.3%

ARDT stock opened at $12.65 on Tuesday. The stock has a market capitalization of $1.81 billion, a P/E ratio of 6.99, a price-to-earnings-growth ratio of 5.78 and a beta of 0.29. The company has a current ratio of 2.13, a quick ratio of 2.00 and a debt-to-equity ratio of 0.66. Ardent Health has a 12 month low of $10.10 and a 12 month high of $20.72. The firm has a 50-day moving average price of $12.30 and a 200-day moving average price of $13.11.

Ardent Health (NYSE:ARDT) last posted its earnings results on Tuesday, August 5th. The company reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.22. The firm had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. As a group, equities research analysts anticipate that Ardent Health will post 1.23 EPS for the current fiscal year.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.